Akili, Inc. launches EndeavorOTC digital therapeutic for adult ADHD

Akili, Inc. (Nasdaq: AKLI), a leader in digital therapeutics, has announced a significant breakthrough with the U.S. Food and Drug Administration (FDA) clearance of its ... Read More